United States Biosimilars Industry 2016 Market Research Report

Published Date : 2016-02-16

Published By : QY Research Reports

Category : Pharma & Healthcare

No. of Pages : 136

The United States Biosimilars Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Biosimilars industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Biosimilars market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Biosimilars industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 156 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Table of Contents



1 Industry Overview

1.1 Definition and Specifications of Biosimilars

1.2 Classification of Biosimilars

1.3 Applications of Biosimilars

1.4 Industry Chain Structure of Biosimilars

1.5 Industry Overview of Biosimilars

1.6 Industry Policy Analysis of Biosimilars

1.7 Industry News Analysis of Biosimilars



2 Manufacturing Cost Structure Analysis of Biosimilars

2.1 Bill of Materials (BOM) of Biosimilars

2.2 BOM Price Analysis of Biosimilars

2.3 Labor Cost Analysis of Biosimilars

2.4 Depreciation Cost Analysis of Biosimilars

2.5 Manufacturing Cost Structure Analysis of Biosimilars

2.6 Manufacturing Process Analysis of Biosimilars

2.7 United States Price, Cost and Gross of Biosimilars 2011-2016



3 Technical Data and Manufacturing Plants Analysis

3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015

3.2 Manufacturing Plants Distribution of United States Key Biosimilars Manufacturers in 2015

3.3 R&D Status and Technology Source of United States Biosimilars Key Manufacturers in 2015

3.4 Raw Materials Sources Analysis of United States Biosimilars Key Manufacturers in 2015



4 Production Analysis of Biosimilars by Regions, Type, and Applications

4.1 United States Production of Biosimilars by Regions 2011-2016

4.2 United States Production of Biosimilars by Type 2011-2016

4.3 United States Sales of Biosimilars by Applications 2011-2016

4.4 Price Analysis of United States Biosimilars Key Manufacturers in 2015

4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Biosimilars 2011-2016



5 Consumption Volume and Consumption Value Analysis of Biosimilars by Regions

5.1 United States Consumption Volume of Biosimilars by Regions 2011-2016

5.2 United States Consumption Value of Biosimilars by Regions 2011-2016

5.3 United States Consumption Price Analysis of Biosimilars by Regions 2011-2016



6 Analysis of Biosimilars Production, Supply, Sales and Market Status 2011-2016

6.1 Capacity, Production, Sales, and Revenue of Biosimilars 2011-2016

6.2 Production Market Share and Sales Market Share Analysis of Biosimilars 2014-2015

6.3 Sales Overview of Biosimilars 2011-2016

6.4 Supply, Consumption and Gap of Biosimilars 2011-2016

6.5 Import, Export and Consumption of Biosimilars 2011-2016

6.6 Cost, Price, Revenue and Gross Margin of Biosimilars 2011-2016



7 Analysis of Biosimilars Industry Key Manufacturers

7.1 SANDOZ (Novartis)

7.1.1 Company Profile

7.1.2 Product Picture and Specification

7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.1.4 SANDOZ (Novartis) SWOT Analysis



7.2 Teva Pharmaceutical

7.2.1 Company Profile

7.2.2 Product Picture and Specification

7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.2.4 Teva Pharmaceutical SWOT Analysis



7.3 Hospira (Pfizer)

7.3.1 Company Profile

7.3.2 Product Picture and Specification

7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.3.4 Hospira (Pfizer) SWOT Analysis



7.4 MYLAN

7.4.1 Company Profile

7.4.2 Product Picture and Specification

7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.4.4 MYLAN SWOT Analysis



7.5 3sbio

7.5.1 Company Profile

7.5.2 Product Picture and Specification

7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.5.4 3sbio SWOT Analysis



7.6 Changchun High Tech

7.6.1 Company Profile

7.6.2 Product Picture and Specification

7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.6.4 Changchun High Tech SWOT Analysis



7.7 CP Guojian Pharmacy

7.7.1 Company Profile

7.7.2 Product Picture and Specification

7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.7.4 CP Guojian Pharmacy SWOT Analysis



7.8 Biotech Pharma

7.8.1 Company Profile

7.8.2 Product Picture and Specification

7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.8.4 Biotech Pharma SWOT Analysis



7.9 Gelgen Biopharma

7.9.1 Company Profile

7.9.2 Product Picture and Specification

7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue

7.9.4 Gelgen Biopharma SWOT Analysis



8 Price and Gross Margin Analysis

8.1 Analysis of Price

8.2 Gross Margin Analysis

8.3 Price Comparison by Regions

8.4 Price Analysis of Different Biosimilars Product Types

8.5 Market Share Analysis of Different Biosimilars Price Levels

8.6 Gross Margin Analysis of Different Biosimilars Applications



9 Marketing Trader or Distributor Analysis of Biosimilars

9.1 Marketing Channels Status of Biosimilars

9.2 Traders or Distributors of Biosimilars with Contact Information

9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Biosimilars

9.4 United States Import, Export and Trade Analysis of Biosimilars



10 Development Trend of Biosimilars Industry 2016-2021

10.1 Capacity and Production Overview of Biosimilars 2016-2021

10.2 Production Market Share by Product Types of Biosimilars 2016-2021

10.3 Sales and Sales Revenue Overview of Biosimilars 2016-2021

10.4 United States Sales of Biosimilars by Applications 2016-2021

10.5 Import, Export and Consumption of Biosimilars 2016-2021

10.6 Cost, Price, Revenue and Gross Margin of Biosimilars 2016-2021



11 Industry Chain Suppliers of Biosimilars with Contact Information

11.1 Major Raw Materials Suppliers of Biosimilars with Contact Information

11.2 Manufacturing Equipment Suppliers of Biosimilars with Contact Information

11.3 Major Players of Biosimilars with Contact Information

11.4 Key Consumers of Biosimilars with Contact Information

11.5 Supply Chain Relationship Analysis of Biosimilars



12 New Project Investment Feasibility Analysis of Biosimilars

12.1 New Project SWOT Analysis of Biosimilars

12.2 New Project Investment Feasibility Analysis of Biosimilars



13 Conclusion of the United States Biosimilars Industry 2016 Market Research Report






List of Tables and Figures



Figure Picture of Biosimilars

Table Product Specifications of Biosimilars

Table Classification of Biosimilars

Figure United States Sales Market Share of Biosimilars by Product Types in 2015

Table Applications of Biosimilars

Figure United States Sales Market Share of Biosimilars by Applications in 2015

Figure Industry Chain Structure of Biosimilars

Table United States Industry Overview of Biosimilars

Table Industry Policy of Biosimilars

Table Industry News List of Biosimilars

Table Bill of Materials (BOM) of Biosimilars

Table Bill of Materials (BOM) Price of Biosimilars

Table Labor Cost of Biosimilars

Table Depreciation Cost of Biosimilars

Table Manufacturing Cost Structure Analysis of Biosimilars in 2015

Figure Manufacturing Process Analysis of Biosimilars

Table United States Price Analysis of Biosimilars 2011-2016 (USD/Unit)

Table United States Cost Analysis of Biosimilars 2011-2016 (USD/Unit)

Table United States Gross Analysis of Biosimilars 2011-2016

Table Capacity (K Units) and Commercial Production Date of United States Biosimilars Key Manufacturers in 2015

Table Manufacturing Plants Distribution of United States Key Biosimilars Manufacturers in 2015

Table R&D Status and Technology Source of United States Biosimilars Key Manufacturers in 2015

Table Raw Materials Sources Analysis of United States and United States Biosimilars Key Manufacturers in 2015

Table United States Production of Biosimilars by Regions 2011-2016 (K Units)

Table United States Production Market Share of Biosimilars by Regions 2011-2016

Figure United States Production Market Share of Biosimilars by Regions in 2014

Figure United States Production Market Share of Biosimilars by Regions in 2015

Table United States Production of Biosimilars by Types in 2011-2016 (K Units)

Table United States Production Market Share of Biosimilars by Type in 2011-2016

Figure United States Production Market Share of Biosimilars by Type in 2014

Figure United States Production Market Share of Biosimilars by Type in 2015

Table United States Sales of Biosimilars by Applications 2011-2016 (K Units)

Table United States Production Market Share of Biosimilars by Applications 2011-2016

Figure United States Production Market Share of Biosimilars by Applications in 2014

Figure United States Production Market Share of Biosimilars by Applications in 2015

Table Price Comparison of United States Biosimilars Key Manufacturers in 2015 (USD/Unit)

Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Biosimilars 2011-2016

Table United States Consumption Volume of Biosimilars by Regions 2011-2016 (K Units)

Table United States Consumption Volume Market Share of Biosimilars by Regions 2011-2016

Figure United States Consumption Volume Market Share of Biosimilars by Regions in 2014

Figure United States Consumption Volume Market Share of Biosimilars by Regions in 2015

Table United States Consumption Value of Biosimilars by Regions 2011-2016 (M USD)

Table United States Consumption Value Market Share of Biosimilars by Regions 2011-2016

Figure United States Consumption Value Market Share of Biosimilars by Regions in 2014

Figure United States Consumption Value Market Share of Biosimilars by Regions in 2015

Table Consumption Price of Biosimilars by Regions 2011-2016 (USD/Unit)

Table United States and Major Manufacturers Capacity of Biosimilars 2011-2016 (K Units)

Table United States Capacity Market Share of Major Biosimilars Manufacturers 2011-2016

Table United States and Major Manufacturers Production of Biosimilars 2011-2016 (K Units)

Table United States Production Market Share of Major Biosimilars Manufacturers 2011-2016

Table United States and Major Manufacturers Sales of Biosimilars 2011-2016 (K Units)

Table United States Sales Market Share of Major Biosimilars Manufacturers 2011-2016

Table United States and Major Manufacturers Sales Revenue of Biosimilars 2011-2016 (M USD)

Table United States Sales Revenue Market Share of Major Biosimilars Manufacturers 2011-2016

Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Biosimilars 2011-2016

Figure United States Capacity Utilization Rate of Biosimilars 2011-2016

Figure United States Sales Revenue (M USD) and Growth Rate of Biosimilars 2011-2016

Figure United States Production Market Share of Major Biosimilars Manufacturers in 2014

Figure United States Production Market Share of Major Biosimilars Manufacturers in 2015

Figure United States Sales Market Share of Major Biosimilars Manufacturers in 2014

Figure United States Sales Market Share of Major Biosimilars Manufacturers in 2015

Figure United States Sales (K Units) and Growth Rate of Biosimilars 2011-2016

Table United States Supply, Consumption and Gap of Biosimilars 2011-2016 (K Units)

Table United States Import, Export and Consumption of Biosimilars 2011-2016 (K Units)

Table Price of United States Biosimilars Major Manufacturers 2011-2016 (USD/Unit)

Table Gross Margin of United States Biosimilars Major Manufacturers 2011-2016

Table United States and Major Manufacturers Revenue of Biosimilars 2011-2016 (M USD)

Table United States Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biosimilars 2011-2016

Table SANDOZ (Novartis) Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of SANDOZ (Novartis)

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of SANDOZ (Novartis) 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of SANDOZ (Novartis) 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of SANDOZ (Novartis) 2011-2016

Table SANDOZ (Novartis) Biosimilars SWOT Analysis

Table Teva Pharmaceutical Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of Teva Pharmaceutical

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Teva Pharmaceutical 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Teva Pharmaceutical 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of Teva Pharmaceutical 2011-2016

Table Teva Pharmaceutical Biosimilars SWOT Analysis

Table Hospira (Pfizer) Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of Hospira (Pfizer)

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Hospira (Pfizer) 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Hospira (Pfizer) 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of Hospira (Pfizer) 2011-2016

Table Hospira (Pfizer) Biosimilars SWOT Analysis

Table MYLAN Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of MYLAN

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of MYLAN 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of MYLAN 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of MYLAN 2011-2016

Table MYLAN Biosimilars SWOT Analysis

Table 3sbio Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of 3sbio

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of 3sbio 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of 3sbio 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of 3sbio 2011-2016

Table 3sbio Biosimilars SWOT Analysis

Table Changchun High Tech Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of Changchun High Tech

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Changchun High Tech 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Changchun High Tech 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of Changchun High Tech 2011-2016

Table Changchun High Tech Biosimilars SWOT Analysis

Table CP Guojian Pharmacy Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of CP Guojian Pharmacy

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of CP Guojian Pharmacy 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of CP Guojian Pharmacy 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of CP Guojian Pharmacy 2011-2016

Table CP Guojian Pharmacy Biosimilars SWOT Analysis

Table Biotech Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of Biotech Pharma

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Biotech Pharma 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Biotech Pharma 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of Biotech Pharma 2011-2016

Table Biotech Pharma Biosimilars SWOT Analysis

Table Gelgen Biopharma Company Profile (Contact Information Plant Location Capacity Revenue etc)

Figure Biosimilars Picture and Specifications of Gelgen Biopharma

Table Biosimilars Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (M USD) and Gross Margin of Gelgen Biopharma 2011-2016

Figure Biosimilars Capacity (K Units), Production (K Units) and Growth Rate of Gelgen Biopharma 2011-2016

Figure Biosimilars Production (K Units) and United States Market Share of Gelgen Biopharma 2011-2016

Table Gelgen Biopharma Biosimilars SWOT Analysis

Table Biosimilars Price by Regions 2011-2016

Table Biosimilars Price by Product Types 2011-2016

Table Biosimilars Price by Companies 2011-2016

Table Biosimilars Gross Margin by Companies 2011-2016

Table Price Comparison of Biosimilars by Regions 2011-2016 (USD/Unit)

Table Price of Different Biosimilars Product Types (USD/Unit)

Table Market Share of Different Biosimilars Price Level

Table Gross Margin of Different Biosimilars Applications

Table Marketing Channels Status of Biosimilars

Table Traders or Distributors of Biosimilars with Contact Information

Table Ex-work Price, Channel Price and End Buyer Price of Biosimilars (USD/Unit) in 2015

Table United States Import, Export, and Trade of Biosimilars (K Units)

Figure United States Capacity (K Units), Production (K Units) and Growth Rate of Biosimilars 2016-2021

Figure United States Capacity Utilization Rate of Biosimilars 2016-2021

Table United States Biosimilars Production by Type 2016-2021 (K Units)

Table United States Biosimilars Production Market Share by Type 2016-2021

Figure United States Production Market Share of Biosimilars by Type in 2021

Figure United States Sales (K Units) and Growth Rate of Biosimilars 2016-2021

Figure United States Sales Revenue (Million USD) and Growth Rate of Biosimilars 2016-2021

Figure United States Sales of Biosimilars by Applications 2016-2021 (K Units)

Table United States Production Market Share of Biosimilars by Applications 2016-2021

Figure United States Production Market Share of Biosimilars by Applications in 2021

Table United States Production, Import, Export and Consumption of Biosimilars 2016-2021 (K Units)

Table United States Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (M USD) and Gross Margin of Biosimilars 2016-2021

Table Major Raw Materials Suppliers of Biosimilars with Contact Information

Table Manufacturing Equipment Suppliers of Biosimilars with Contact Information

Table Major Players of Biosimilars with Contact Information

Table Key Consumers of Biosimilars with Contact Information

Table Supply Chain Relationship Analysis of Biosimilars

Table New Project SWOT Analysis of Biosimilars

Table New Project Investment Feasibility Analysis of Biosimilars

Table Part of Interviewees Record List

Online Payment

Research Assistance
We will be happy to help you find what you need. Please write to us:

E-Addresssales@qyresearchreports.us